1. Home
  2. IKT vs PNBK Comparison

IKT vs PNBK Comparison

Compare IKT & PNBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • PNBK
  • Stock Information
  • Founded
  • IKT 2008
  • PNBK 1999
  • Country
  • IKT United States
  • PNBK United States
  • Employees
  • IKT N/A
  • PNBK N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • PNBK Major Banks
  • Sector
  • IKT Health Care
  • PNBK Finance
  • Exchange
  • IKT Nasdaq
  • PNBK Nasdaq
  • Market Cap
  • IKT 140.5M
  • PNBK 146.4M
  • IPO Year
  • IKT 2020
  • PNBK N/A
  • Fundamental
  • Price
  • IKT $1.56
  • PNBK $1.47
  • Analyst Decision
  • IKT Buy
  • PNBK
  • Analyst Count
  • IKT 2
  • PNBK 0
  • Target Price
  • IKT $8.00
  • PNBK N/A
  • AVG Volume (30 Days)
  • IKT 92.1K
  • PNBK 243.1K
  • Earning Date
  • IKT 11-13-2025
  • PNBK 08-14-2025
  • Dividend Yield
  • IKT N/A
  • PNBK N/A
  • EPS Growth
  • IKT N/A
  • PNBK N/A
  • EPS
  • IKT N/A
  • PNBK N/A
  • Revenue
  • IKT N/A
  • PNBK $15,640,000.00
  • Revenue This Year
  • IKT N/A
  • PNBK N/A
  • Revenue Next Year
  • IKT N/A
  • PNBK N/A
  • P/E Ratio
  • IKT N/A
  • PNBK N/A
  • Revenue Growth
  • IKT N/A
  • PNBK N/A
  • 52 Week Low
  • IKT $1.12
  • PNBK $0.90
  • 52 Week High
  • IKT $4.20
  • PNBK $7.47
  • Technical
  • Relative Strength Index (RSI)
  • IKT 42.51
  • PNBK 46.61
  • Support Level
  • IKT $1.50
  • PNBK $1.41
  • Resistance Level
  • IKT $1.73
  • PNBK $1.51
  • Average True Range (ATR)
  • IKT 0.09
  • PNBK 0.09
  • MACD
  • IKT -0.02
  • PNBK 0.00
  • Stochastic Oscillator
  • IKT 17.34
  • PNBK 46.67

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About PNBK Patriot National Bancorp Inc.

Patriot National Bancorp Inc provides consumer and commercial banking services to individuals, small and medium-sized businesses, professionals, and municipalities in Fairfield and New Haven Counties in Connecticut and Westchester County, New York. Its products include checking accounts, savings accounts, money market accounts, time certificates of deposit, and individual retirement accounts. The Bank's lending portfolio is comprised of commercial mortgage and construction loans, commercial loans, home improvement loans, home equity lines of credit, and other personal loans. In addition, the Bank offers bank checks, money orders, automated teller machines, interactive teller machines, online and mobile banking, credit cards, and debit cards.

Share on Social Networks: